Regeneron Joins Koneksa's Data Syndication Program for Parkinson’s Digital Biomarkers Study
09/03/24, 12:10 PM
Location
new yorkIndustry
biotechnology
health care
Type
partnership
Regeneron has joined Koneksa's Data Syndication Program for the LEARNS observational study, which aims to remotely measure disease progression using digital biomarkers in neurodegenerative disorders.
Company Info
Location
199 water street, 34th floor
new york, new york, united states
Additional Info
Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster. Koneksa aims to revolutionize treatment effect detection in clinical research and improve patient outcomes.